Losartan therapy in patents with Marfan syndrome
Phase of Trial: Phase II
Latest Information Update: 29 Nov 2017
Price : $35 *
At a glance
- Drugs Losartan (Primary)
- Indications Aortic disorders
- Focus Therapeutic Use
- Acronyms COMPARE
- 24 Oct 2013 New trial record
- 02 Sep 2013 Primary endpoint 'Clinical-response-rate' has been met according to results published in the European Heart Journal.
- 02 Sep 2013 Results published in the European Heart Journal.